nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—TNF—metabolic syndrome X	0.734	1	CbGaD
Pseudoephedrine—IL2—blood vessel—metabolic syndrome X	0.0137	0.194	CbGeAlD
Pseudoephedrine—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00983	0.139	CbGeAlD
Pseudoephedrine—NFATC1—cardiovascular system—metabolic syndrome X	0.00668	0.0946	CbGeAlD
Pseudoephedrine—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00661	0.0936	CbGeAlD
Pseudoephedrine—IL2—cardiovascular system—metabolic syndrome X	0.00611	0.0865	CbGeAlD
Pseudoephedrine—IL2—kidney—metabolic syndrome X	0.00598	0.0847	CbGeAlD
Pseudoephedrine—NFATC1—adipose tissue—metabolic syndrome X	0.00589	0.0834	CbGeAlD
Pseudoephedrine—IL2—liver—metabolic syndrome X	0.00378	0.0535	CbGeAlD
Pseudoephedrine—ADRB1—cardiovascular system—metabolic syndrome X	0.00153	0.0217	CbGeAlD
Pseudoephedrine—ADRB1—adipose tissue—metabolic syndrome X	0.00135	0.0191	CbGeAlD
Pseudoephedrine—ADRA1A—cardiovascular system—metabolic syndrome X	0.00121	0.0171	CbGeAlD
Pseudoephedrine—MAOA—cardiovascular system—metabolic syndrome X	0.0012	0.017	CbGeAlD
Pseudoephedrine—MAOA—kidney—metabolic syndrome X	0.00117	0.0166	CbGeAlD
Pseudoephedrine—ADRA1A—adipose tissue—metabolic syndrome X	0.00107	0.0151	CbGeAlD
Pseudoephedrine—MAOA—adipose tissue—metabolic syndrome X	0.00106	0.015	CbGeAlD
Pseudoephedrine—ADRA2A—adipose tissue—metabolic syndrome X	0.000812	0.0115	CbGeAlD
Pseudoephedrine—ADRA1A—liver—metabolic syndrome X	0.000749	0.0106	CbGeAlD
Pseudoephedrine—MAOA—liver—metabolic syndrome X	0.000742	0.0105	CbGeAlD
Pseudoephedrine—CYP2D6—kidney—metabolic syndrome X	0.000698	0.00988	CbGeAlD
Pseudoephedrine—CYP2D6—liver—metabolic syndrome X	0.000441	0.00625	CbGeAlD
Pseudoephedrine—ADRB2—Signaling Pathways—RBP4—metabolic syndrome X	3.24e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PLA2G6—metabolic syndrome X	3.24e-05	0.000165	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	3.22e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOA5—metabolic syndrome X	3.21e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GHRL—metabolic syndrome X	3.2e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	3.18e-05	0.000162	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—ALB—metabolic syndrome X	3.16e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—CCL2—metabolic syndrome X	3.15e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL5—metabolic syndrome X	3.12e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	3.11e-05	0.000159	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AKT1—metabolic syndrome X	3.09e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ABCA1—metabolic syndrome X	3.09e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SLC2A4—metabolic syndrome X	3.09e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HDAC3—metabolic syndrome X	3.08e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL5—metabolic syndrome X	3.05e-05	0.000156	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL6—metabolic syndrome X	3.04e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	3.04e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—IL6—metabolic syndrome X	3.04e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—AKT1—metabolic syndrome X	3.03e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CNR1—metabolic syndrome X	3.03e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GOT1—metabolic syndrome X	2.99e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GGT1—metabolic syndrome X	2.99e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TRIB3—metabolic syndrome X	2.98e-05	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOC3—metabolic syndrome X	2.94e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AGT—metabolic syndrome X	2.88e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOC3—metabolic syndrome X	2.87e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HDAC3—metabolic syndrome X	2.86e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFB1—metabolic syndrome X	2.82e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AGT—metabolic syndrome X	2.81e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—AKT1—metabolic syndrome X	2.81e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—AKT1—metabolic syndrome X	2.8e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CCL5—metabolic syndrome X	2.78e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL6—metabolic syndrome X	2.78e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IGF1—metabolic syndrome X	2.77e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MTNR1B—metabolic syndrome X	2.75e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—FABP4—metabolic syndrome X	2.7e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TRIB3—metabolic syndrome X	2.68e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RBP4—metabolic syndrome X	2.68e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NAMPT—metabolic syndrome X	2.67e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	2.67e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—TGFB1—metabolic syndrome X	2.67e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—LIPC—metabolic syndrome X	2.66e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GCK—metabolic syndrome X	2.66e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HTR2C—metabolic syndrome X	2.65e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOC3—metabolic syndrome X	2.64e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SERPINE1—metabolic syndrome X	2.63e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—ALB—metabolic syndrome X	2.63e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AGT—metabolic syndrome X	2.61e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HTR2C—metabolic syndrome X	2.59e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CCL5—metabolic syndrome X	2.58e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CYBA—metabolic syndrome X	2.57e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—AKT1—metabolic syndrome X	2.57e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CETP—metabolic syndrome X	2.56e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	2.56e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MTNR1B—metabolic syndrome X	2.56e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AGT—metabolic syndrome X	2.55e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APOB—metabolic syndrome X	2.54e-05	0.00013	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL5—metabolic syndrome X	2.53e-05	0.000129	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.52e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GHRL—metabolic syndrome X	2.51e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NOS3—metabolic syndrome X	2.51e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CYBA—metabolic syndrome X	2.51e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RBP4—metabolic syndrome X	2.49e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TRIB3—metabolic syndrome X	2.49e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PLA2G4A—metabolic syndrome X	2.47e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GHRL—metabolic syndrome X	2.46e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SCARB1—metabolic syndrome X	2.45e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—LPL—metabolic syndrome X	2.43e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFB1—metabolic syndrome X	2.39e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SREBF1—metabolic syndrome X	2.38e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CNR1—metabolic syndrome X	2.38e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOC3—metabolic syndrome X	2.38e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL5—metabolic syndrome X	2.35e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.34e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CNR1—metabolic syndrome X	2.33e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AGT—metabolic syndrome X	2.33e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—HMGCR—metabolic syndrome X	2.32e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GOT2—metabolic syndrome X	2.32e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CD36—metabolic syndrome X	2.31e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—G6PD—metabolic syndrome X	2.28e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	2.24e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	2.23e-05	0.000114	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOC3—metabolic syndrome X	2.21e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCKR—metabolic syndrome X	2.18e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—LPA—metabolic syndrome X	2.18e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AGT—metabolic syndrome X	2.16e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CCL2—metabolic syndrome X	2.15e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HTR2C—metabolic syndrome X	2.14e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PPARA—metabolic syndrome X	2.14e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL6—metabolic syndrome X	2.13e-05	0.000109	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AGT—metabolic syndrome X	2.11e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	2.11e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CCL2—metabolic syndrome X	2.1e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOA5—metabolic syndrome X	2.09e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CYBA—metabolic syndrome X	2.08e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AGT—metabolic syndrome X	2.08e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ABCA1—metabolic syndrome X	2.07e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SLC2A4—metabolic syndrome X	2.07e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APOE—metabolic syndrome X	2.03e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GHRL—metabolic syndrome X	2.03e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—IL6—metabolic syndrome X	2.01e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APOA1—metabolic syndrome X	2.01e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GGT1—metabolic syndrome X	2e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GOT1—metabolic syndrome X	2e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HTR2C—metabolic syndrome X	1.99e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AGT—metabolic syndrome X	1.96e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKT1—metabolic syndrome X	1.96e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF2—metabolic syndrome X	1.95e-05	9.93e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	1.94e-05	9.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CYBA—metabolic syndrome X	1.93e-05	9.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CNR1—metabolic syndrome X	1.93e-05	9.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF2—metabolic syndrome X	1.9e-05	9.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GHRL—metabolic syndrome X	1.89e-05	9.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOB—metabolic syndrome X	1.89e-05	9.64e-05	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—AKT1—metabolic syndrome X	1.86e-05	9.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOB—metabolic syndrome X	1.85e-05	9.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL5—metabolic syndrome X	1.84e-05	9.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.84e-05	9.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL5—metabolic syndrome X	1.8e-05	9.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LPL—metabolic syndrome X	1.8e-05	9.2e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL6—metabolic syndrome X	1.8e-05	9.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.8e-05	9.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CNR1—metabolic syndrome X	1.79e-05	9.13e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PPARG—metabolic syndrome X	1.77e-05	9.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LPL—metabolic syndrome X	1.76e-05	9e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	1.74e-05	8.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CCL2—metabolic syndrome X	1.74e-05	8.88e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—INS—metabolic syndrome X	1.74e-05	8.87e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—LIPC—metabolic syndrome X	1.73e-05	8.84e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GCK—metabolic syndrome X	1.73e-05	8.84e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOC3—metabolic syndrome X	1.72e-05	8.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOB—metabolic syndrome X	1.7e-05	8.67e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CETP—metabolic syndrome X	1.67e-05	8.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	1.66e-05	8.48e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—metabolic syndrome X	1.66e-05	8.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	1.65e-05	8.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—LPL—metabolic syndrome X	1.62e-05	8.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	1.62e-05	8.25e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	1.6e-05	8.16e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ALB—metabolic syndrome X	1.59e-05	8.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF2—metabolic syndrome X	1.57e-05	8.03e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	1.55e-05	7.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AGT—metabolic syndrome X	1.54e-05	7.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CD36—metabolic syndrome X	1.54e-05	7.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	1.53e-05	7.8e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NOS3—metabolic syndrome X	1.52e-05	7.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—LEP—metabolic syndrome X	1.51e-05	7.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOE—metabolic syndrome X	1.51e-05	7.72e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GOT2—metabolic syndrome X	1.51e-05	7.71e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	1.51e-05	7.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AGT—metabolic syndrome X	1.51e-05	7.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOA1—metabolic syndrome X	1.49e-05	7.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	1.49e-05	7.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.49e-05	7.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOE—metabolic syndrome X	1.48e-05	7.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—LEP—metabolic syndrome X	1.48e-05	7.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	1.46e-05	7.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOA1—metabolic syndrome X	1.46e-05	7.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	1.46e-05	7.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARA—metabolic syndrome X	1.43e-05	7.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	1.42e-05	7.25e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—metabolic syndrome X	1.39e-05	7.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AGT—metabolic syndrome X	1.39e-05	7.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	1.39e-05	7.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.38e-05	7.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOE—metabolic syndrome X	1.36e-05	6.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	1.36e-05	6.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IRS1—metabolic syndrome X	1.35e-05	6.88e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.35e-05	6.87e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.35e-05	6.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOA1—metabolic syndrome X	1.34e-05	6.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IRS1—metabolic syndrome X	1.32e-05	6.73e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.3e-05	6.66e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.3e-05	6.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—INS—metabolic syndrome X	1.29e-05	6.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCL2—metabolic syndrome X	1.27e-05	6.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—INS—metabolic syndrome X	1.26e-05	6.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	1.25e-05	6.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.25e-05	6.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	1.24e-05	6.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.22e-05	6.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.22e-05	6.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	1.22e-05	6.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.21e-05	6.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.19e-05	6.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.18e-05	6.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—INS—metabolic syndrome X	1.16e-05	5.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.16e-05	5.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.16e-05	5.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.15e-05	5.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.14e-05	5.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.14e-05	5.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	1.13e-05	5.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.12e-05	5.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	1.11e-05	5.65e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.11e-05	5.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.09e-05	5.57e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.08e-05	5.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.06e-05	5.43e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.06e-05	5.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.04e-05	5.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.03e-05	5.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.02e-05	5.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.01e-05	5.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.01e-05	5.16e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CD36—metabolic syndrome X	1e-05	5.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	9.71e-06	4.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.7e-06	4.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.6e-06	4.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	9.55e-06	4.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	9.55e-06	4.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	9.49e-06	4.85e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	9.39e-06	4.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	9.34e-06	4.77e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	9.33e-06	4.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	9.31e-06	4.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	9.16e-06	4.68e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AGT—metabolic syndrome X	9.04e-06	4.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.92e-06	4.55e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOE—metabolic syndrome X	8.86e-06	4.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	8.81e-06	4.5e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	8.75e-06	4.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	8.62e-06	4.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	8.51e-06	4.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.85e-06	4.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	7.73e-06	3.94e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	7.71e-06	3.94e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—INS—metabolic syndrome X	7.57e-06	3.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	7.49e-06	3.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	7.32e-06	3.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.29e-06	3.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	7.18e-06	3.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.13e-06	3.64e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—metabolic syndrome X	7e-06	3.58e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ALB—metabolic syndrome X	6.94e-06	3.54e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	6.63e-06	3.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.62e-06	3.38e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.07e-06	3.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.06e-06	3.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	5.64e-06	2.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.63e-06	2.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	5.52e-06	2.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	5.21e-06	2.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	5.09e-06	2.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.68e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.57e-06	2.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.24e-06	2.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	4.21e-06	2.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	3.91e-06	2e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.05e-06	1.56e-05	CbGpPWpGaD
